Abeona Therapeutics Inc (ABEO)
SG&A Expense Growth
-15.02%
Quarterly · Period ending:
ABEO SG&A Expense Growth
Latest reported-15.02%period ending
Latest reported-15.02%period ending
ABEO Quarterly SG&A Growth (QoQ) (0.00% → -15.02%)
Latest values, visible window
High-resolution chart · PNG
ABEO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -15.0164% | |
| -0.7933% | |
| -2.7545% | |
| 12.6246% | |
| 75.2401% | |
| 41.785% | |
| 7.7764% | |
| -25.9311% | |
| 21.3814% | |
| 39.4206% | |
| 22.9307% | |
| -17.2276% | |
| 25.6192% | |
| -29.6551% | |
| 46.0668% | |
| 12.4277% | |
| -18.0871% | |
| -3.6277% | |
| -24.6389% | |
| 12.2347% | |
| -17.4841% | |
| -15.1007% | |
| 66.8998% | |
| -19.9711% | |
| -13.6307% | |
| 35.4457% | |
| 0.7234% | |
| -16.2509% | |
| -0.8305% | |
| -25.842% | |
| 53.5412% | |
| 7.413% | |
| 60.7714% | |
| -7.549% | |
| 43.7211% | |
| -18.0167% | |
| -12.5745% | |
| 7.8131% | |
| 17.2313% | |
| -35.8981% | |
| -14.5671% | |
| 2.802% | |
| -9.964% | |
| 28.6338% | |
| 117.1107% | |
| 157.0776% | |
| -17.3585% | |
| -8.4101% | |
| -37.6437% | |
| 94.1423% | |
| 11.6822% | |
| -69.9579% | |
| 59.716% | |
| -12.7202% | |
| 7.8059% | |
| 1.138% | |
| -15.454% | |
| 113.7532% | |
| -56.8257% | |
| 28.3476% | |
| 36.8421% | |
| -14.1423% | |
| 2.5751% | |
| -7.0231% | |
| 39.5323% | |
| -0.2222% | |
| -73.9734% | |
| 129.4625% | |
| 20.85% | |
| 28.8223% | |
| -32.7311% | |
| 37.8352% | |
| 17.4353% | |
| 7.8883% | |
| -17.6% | |
| -10.1527% | |
| -2.2827% | |
| 66.5205% | |
| -14.5% | |
| 20.6637% | |
| -0.4505% | |
| -53.75% | |
| 107.7922% | |
| -61.8392% | |
| 163.5704% | |
| -21.167% | |
| 9.3867% | |
| 3.4974% | |
| 2.3873% | |
| -9.7006% | |
| 63.0859% | |
| -18.7302% | |
| 17.3184% | |
| -29.1557% | |
| 68.8196% | |
| -21.366% | |
| 14.4289% | |
| -17.2471% | |
| 31.9475% | |
| -1.2959% |